Delivery Order SPE2DB22D3501-SPE2DB25FUX94
Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ganirelix Acetate 250 mcg/0.5 mL injections, with a firm fixed price ceiling value of $6,522.97 and a performance period ending on May 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,058.04, is for the delivery of the drug Ganirelix Acetate 250 MCG/0.5 ML 0.5ML. It has an ultimate completion date of December 11, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558972905 GANIRELIX ACET 250 MCG/0.5 ML 0.5ML. The contract, valued at $3,388.08, is a firm fixed price delivery order with a completion date of November 3, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This delivery order, awarded on June 27, 2025, provides for the supply of Ganirelix Acetate 250 micrograms/0.5 milliliters to support federal healthcare operations. The contract, valued at $3,724.00, represents a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen Drug Corp through the Defense Logistics Agency's Medical Supply Chain. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with an ultimate...
- The Defense Logistics Agency awarded a $5,573.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Ganirelix Acetate 250 micrograms/0.5 milliliters. This is a non-set-aside competitive award with an ultimate completion date of January 14, 2026. The product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a task order issued under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $101,892.98, is for the delivery of Gonal-F RFF Redi-Ject 900 Unit 1.5ML medical supplies. The contract is a Firm Fixed Price delivery order with a performance period extending to February 3, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of GONAL-F RFF REDI-JECT pharmaceutical products, with a total ceiling value of $5,198.00. The contract is a firm fixed-price delivery order, with an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,852.82 firm fixed-price contract is for the supply of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a prescription medication. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,746.69 firm fixed-price delivery order is for the supply of Ganirelix Acetate, a medication used in infertility treatments. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
- This is a $16,462.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical supplies with a period of performance through February 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...